ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxel vs. 5-FU, Leucovorin, & Liposomal Irinotecan in Older Pts With Treatment-Naïve Metastatic Pancreatic Cancer"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxel vs. 5-FU, Leucovorin, & Liposomal Irinotecan in Older Pts With Treatment-Naïve Metastatic Pancreatic Cancer"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Efrat Dotan

426 views

June 7, 2024

0 Comments

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

2024 ASCO® Annual Meeting Insights Hub: GI Videos

09:25

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including T…

Feat. N. Uboha, K. Spencer, M. Cecchini

09:05

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancer…

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini

04:01

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tisleliz…

Feat. H. Yoon

View All

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Feat. L. Zheng

27:37

ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini

23:58

ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta

08:34

Yale Cancer Center

NORPACT-1 Trial Updates: Neoadjuvant FOLFIRINOX vs. Upfront Surgery …

Feat. J. Lacy

20:07

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron

31:40

Horizon CME

Updates in Perioperative Therapy of Pancreatic Cancer

Feat. P. Philip

07:42

Integrity Continuing Education

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Feat. W. Burns

03:50

UCLA Health

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

Feat. Z. Wainberg

12:08

Yale Cancer Center

GI Oncology Year in Review: Precision Medicine Update in Metastatic …

Feat. J. Lacy

07:37

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "EXPEL-PANC - A Ph2 Study of BXCL701 + Pem…

Feat. B. Weinberg

08:08

Integrity Continuing Education

Updates in Nonmetastatic Upper-GI Adenocarcinoma

Feat. J. Hernandez

07:53

Total Health

Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia

Feat. D. Lin

39:04

2023 Johns Hopkins Updates in Gastrointestinal Cancers

Localized Pancreatic Cancer Controversial Cases: Panel Discussion

Feat. M. Katz, A. De Jesus-Acosta, N. Zaidi, J. He, A. Narang, T. Bekaii-Saab

10:53

Yale Cancer Center

GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …

Feat. J. Lacy

25:56

OncoAlert

Year in Review: Pancreatic Cancers

Feat. M. Lewis

30:55

2023 Johns Hopkins Updates in Gastrointestinal Cancers

Medical Oncology Updates in Pancreas Cancer

Feat. T. Bekaii-Saab

06:28

Shubham Pant

FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…

22:10

Yale Cancer Center

Pancreatic Cancer Updates From Yale Cancer Center

Feat. J. Lacy

17:05

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "A Multicenter, Randomized, Open-Label, Thr…

Feat. A. Ohba

18:35

Rachna Shroff

Login

Login

Join VuMedi

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxel vs. 5-FU, Leucovorin, & Liposomal Irinotecan in Older Pts With Treatment-Naïve Metastatic Pancreatic Cancer"

2024 ASCO® Annual Meeting Insights Hub: GI Videos

Related Content